552-66-9
Chemical Structure
Daidzin
Synonym(s): Daidzoside; NPI-031D; Daidzein 7-O-glucoside
- No. CAS: 552-66-9
- Formula:C21H20O9
- Molecular Weight:416.38
IUPAC Name: 3-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
InChIKey: KYQZWONCHDNPDP-QNDFHXLGSA-N
SMILES: OC1=CC=C(C2=COC(C=C(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C4)=C4C2=O)C=C1
Biological Activity: Daidzin is an isoflavone with antioxidant, anticancer, and antiatherosclerotic activities. Daidzin is a potent and selective inhibitor of mitochondrial ALDH-2. Daidzin reduces ethanol consumption[1].
| Referencia número | Nombre del producto | Pureza | Descripciòn | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Daidzin | 99.65% | Daidzin is an isoflavone with antioxidant, anticancer, and antiatherosclerotic activities. Daidzin is a potent and selective inhibitor of mitochondrial ALDH-2. Daidzin reduces ethanol consumption. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Daidzin (Standard) | 99.21% | Daidzin (Standard) is the analytical standard of Daidzin. This product is intended for research and analytical applications. Daidzin is an isoflavone with antioxidant, anticancer, and antiatherosclerotic activities. Daidzin is a potent and selective inhibitor of mitochondrial ALDH-2. Daidzin reduces ethanol consumption. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.92
HY-N8899Daidzein-4'-glucoside -
Similarity Score 0.91
HY-N0270ROnonin (Standard) -
Similarity Score 0.89
HY-N41284''-methyloxy-Daidzin -
Similarity Score 0.87
HY-N40716"-O-Acetyldaidzin -
Similarity Score 0.85
HY-N8841Daidzein-7-O-glucuronide -
Similarity Score 0.84
HY-N0520RCalycosin-7-O-β-D-glucoside (Standard) -
Similarity Score 0.83
HY-N91063′-Methoxydaidzin -
Similarity Score 0.83
HY-N40736"-O-Malonyldaidzin -
Similarity Score 0.82
HY-N0595RGenistin (Standard) -
Explore the MedChemAI to find more analogs